Viewing Study NCT02438761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:38 PM
Ignite Modification Date: 2026-02-21 @ 11:17 PM
Study NCT ID: NCT02438761
Status: TERMINATED
Last Update Posted: 2025-09-08
First Post: 2015-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML) (LAM-PIK)
Sponsor: Institut Curie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome View
None Acute Myeloid Leukemia, in Relapse View
None de Novo Acute Myeloid Leukemia at Diagnostic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute Myeloid Leukemia View
None Myelodysplastic Syndrome View
None PIK/Akt/mTor View